DARPA investment in peripheral nerve interfaces for prosthetics, prescriptions, and plasticity.
J Neurosci Methods
; 332: 108539, 2020 02 15.
Article
en En
| MEDLINE
| ID: mdl-31805301
ABSTRACT
BACKGROUND:
Peripheral nerve interfaces have emerged as alternative solutions for a variety of therapeutic and performance improvement applications. The Defense Advanced Research Projects Agency (DARPA) has widely invested in these interfaces to provide motor control and sensory feedback to prosthetic limbs, identify non-pharmacological interventions to treat disease, and facilitate neuromodulation to accelerate learning or improve performance on cognitive, sensory, or motor tasks. In this commentary, we highlight some of the design considerations for optimizing peripheral nerve interfaces depending on the application space. We also discuss the ethical considerations that accompany these advances.Palabras clave
Texto completo:
1
Colección:
01-internacional
Banco de datos:
MEDLINE
Asunto principal:
Miembros Artificiales
Idioma:
En
Revista:
J Neurosci Methods
Año:
2020
Tipo del documento:
Article